Beyond Borders: Scaling US Medtech Startups
Europe is the world’s second-largest healthcare market, worth over $140 billion in Medtech sales annually, and home to more than 400 million patients covered by public health systems. For U.S. startups, this represents a major opportunity to expand beyond domestic markets, especially in areas like chronic and metabolic diseases, where demand for smarter, data-driven, and AI powered solutions continues to grow. At the same time, Europe is far from a single market: regulations, reimbursement, and clinical practices vary widely across countries, making the right strategy and local support essential.
On October 29, 2025, Mind the Bridge, together with Theras Group — Italy’s leading distributor of medical devices for chronic pain and metabolic conditions — will host a focused session on how U.S. Medtech startups can effectively approach the European market. The discussion will explore how to shape commercial and clinical strategies, navigate regulatory and reimbursement frameworks, and drive adoption across diverse healthcare systems.
_____________________________________________________________
Agenda details are being finalized
17.30 Welcome
Marco Marinucci, CEO, Mind the Bridge
Davide Corriero, Consul, Consulate General of Italy in San Francisco
17.45 Fireside Chat - From Startup to Global Distributor
Alberto Onetti, Chairman, Mind the Bridge
Massimo Balestri, General Manager, Theras Group
Report: The Future of MedTech: European and Global Trends
in Chronic Therapeutics
18.15 Industry Panel - Expanding in the European Market
Saumitra Thakur MD, Managing Director, MedMountain Ventures
Dorian Averbuch, 4 times Medtech Entrepreneur (2 exits), CEO & Founder, Provect.AI
Alex Gonzalez, Director of International Business Development and Distributor Partnerships, Levita
Matteo Centola, Corporate Innovation Director, Theras Group
19.00 Networking Cocktail Reception
#medtech #healthtech #digitalhealth #AI